Monoamine oxidase inhibitor: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 July 2024

  • curprev 16:0816:08, 9 July 2024‎ Ai talk contribs‎ 5,781 bytes +5,781‎ Created page with "== Introduction == Monoamine oxidase inhibitors (MAOIs) are a class of medications used primarily in the treatment of depression. They function by inhibiting the activity of monoamine oxidase enzymes, which are responsible for breaking down neurotransmitters such as serotonin, norepinephrine, and dopamine in the brain. By preventing the breakdown of these neurotransmitters, MAOIs increase their availability, which can help alleviate depressive symptoms. == Mechanism of..."
Retrieved from "https://canonica.ai/page/Monoamine_oxidase_inhibitor"